Evidence map›Paper›PMID 36829956›Full record

ReviewAntioxidants (Basel, Switzerland)2023

Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics.

Eva Ramos, Emilio Gil-Martín, Cristóbal De Los Ríos, Javier Egea, Francisco López-Muñoz, René Pita, Antonio Juberías, Juan J Torrado, Dolores R Serrano, Russel J Reiter and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Melatonin and angiogenesis potential in stem cells.Stem cell research & therapy · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Melatonin's Impact on Wound Healing.Antioxidants (Basel, Switzerland) · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Biomolecules · 2023
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Eva RamosDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0001-5791-0687
Emilio Gil-MartínDepartment of Biochemistry, Genetics and Immunology, Faculty of Biology, University of Vigo, 36310 Vigo, Spain.ORCID 0000-0002-9435-0444
Cristóbal De Los RíosHealth Research Institute, Hospital Universitario de la Princesa, 28006 Madrid, Spain.ORCID 0000-0002-6456-7589
Javier EgeaMolecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de la Princesa, 28006 Madrid, Spain.ORCID 0000-0003-4704-3019
Francisco López-MuñozFaculty of Health, Camilo José Cela University of Madrid (UCJC), 28692 Madrid, Spain.ORCID 0000-0002-5188-6038
René PitaChemical Defense Department, Chemical, Biological, Radiological, and Nuclear Defense School, Hoyo de Manzanares, 28240 Madrid, Spain.ORCID 0000-0003-3745-9141
Antonio JuberíasDirección de Sanidad Ejército del Aire, Cuartel General Ejército del Aire, 28008 Madrid, Spain.
Juan J TorradoDepartment of Pharmaceutics and Food Technology, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0002-7823-1904
Dolores R SerranoDepartment of Pharmaceutics and Food Technology, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0002-0475-8420
Russel J ReiterDepartment of Cell Systems and Anatomy, UT Health, San Antonio, TX 78229, USA.ORCID 0000-0001-6763-4225
Alejandro RomeroDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain.ORCID 0000-0001-5483-4973
Universidad Complutense de Madrid · ESHospital Universitario Santa Cristina · ESResearch Institute Hospital 12 de Octubre · ESThe University of Texas Health Science Center at San Antonio · USUniversidade de Vigo · ESUniversidad Rey Juan Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfur and nitrogen mustards, bis(2-chloroethyl)sulfide and tertiary bis(2-chloroethyl) amines, respectively, are vesicant warfare agents with alkylating activity. Moreover, oxidative/nitrosative stress, inflammatory response induction, metalloproteinases activation, DNA damage or calcium disruption are some of the toxicological mechanisms of sulfur and nitrogen mustard-induced injury that affects the cell integrity and function. In this review, we not only propose melatonin as a therapeutic option in order to counteract and modulate several pathways involved in physiopathological mechanisms activated after exposure to mustards, but also for the first time, we predict whether metabolites of melatonin, cyclic-3-hydroxymelatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, and N1-acetyl-5-methoxykynuramine could be capable of exerting a scavenger action and neutralize the toxic damage induced by these blister agents. NLRP3 inflammasome is activated in response to a wide variety of infectious stimuli or cellular stressors, however, although the precise mechanisms leading to activation are not known, mustards are postulated as activators. In this regard, melatonin, through its anti-inflammatory action and NLRP3 inflammasome modulation could exert a protective effect in the pathophysiology and management of sulfur and nitrogen mustard-induced injury. The ability of melatonin to attenuate sulfur and nitrogen mustard-induced toxicity and its high safety profile make melatonin a suitable molecule to be a part of medical countermeasures against blister agents poisoning in the near future.

Indexed as

DNA damagemelatoninmelatonin metabolitesNLRP3 inflammasomeoxidative stresssulfur and nitrogen mustard

Identifiers

PMID36829956
PMCPMC9952307
OpenAlexW4319439803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.